Cardinal Health, Inc. (NYSE:CAH) Shares Acquired by Van Lanschot Kempen Investment Management N.V.

Van Lanschot Kempen Investment Management N.V. grew its stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 1.1% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 254,605 shares of the company's stock after purchasing an additional 2,681 shares during the quarter. Van Lanschot Kempen Investment Management N.V. owned about 0.11% of Cardinal Health worth $30,112,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Rothschild Investment LLC increased its holdings in shares of Cardinal Health by 10.1% in the fourth quarter. Rothschild Investment LLC now owns 858 shares of the company's stock worth $101,000 after purchasing an additional 79 shares during the last quarter. Private Trust Co. NA raised its holdings in shares of Cardinal Health by 11.0% during the 4th quarter. Private Trust Co. NA now owns 930 shares of the company's stock worth $110,000 after acquiring an additional 92 shares in the last quarter. Checchi Capital Advisers LLC raised its stake in Cardinal Health by 2.7% during the fourth quarter. Checchi Capital Advisers LLC now owns 3,479 shares of the company's stock valued at $411,000 after purchasing an additional 93 shares in the last quarter. TIAA Trust National Association raised its position in shares of Cardinal Health by 4.5% during the 4th quarter. TIAA Trust National Association now owns 2,183 shares of the company's stock valued at $258,000 after buying an additional 94 shares in the last quarter. Finally, MWA Asset Management lifted its holdings in shares of Cardinal Health by 2.9% in the 4th quarter. MWA Asset Management now owns 3,324 shares of the company's stock valued at $393,000 after acquiring an additional 95 shares during the last quarter. 87.17% of the stock is owned by hedge funds and other institutional investors.

Cardinal Health Trading Up 1.3 %

Cardinal Health stock traded up $1.80 during mid-day trading on Friday, hitting $137.64. The company had a trading volume of 1,804,028 shares, compared to its average volume of 2,182,946. The company has a market capitalization of $33.25 billion, a price-to-earnings ratio of 25.68, a P/E/G ratio of 1.49 and a beta of 0.61. The company's fifty day moving average is $130.59 and its 200-day moving average is $123.78. Cardinal Health, Inc. has a 12-month low of $93.17 and a 12-month high of $139.50.

Cardinal Health (NYSE:CAH - Get Free Report) last released its quarterly earnings data on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, beating analysts' consensus estimates of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. As a group, sell-side analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st were issued a $0.5056 dividend. This represents a $2.02 annualized dividend and a yield of 1.47%. The ex-dividend date of this dividend was Tuesday, April 1st. Cardinal Health's payout ratio is currently 37.69%.

Analysts Set New Price Targets

Several research firms recently weighed in on CAH. Morgan Stanley increased their price target on Cardinal Health from $136.00 to $142.00 and gave the company an "overweight" rating in a report on Friday, January 31st. Mizuho increased their price objective on shares of Cardinal Health from $142.00 to $150.00 and gave the stock an "outperform" rating in a research report on Monday, March 31st. JPMorgan Chase & Co. upped their target price on Cardinal Health from $142.00 to $145.00 and gave the company a "neutral" rating in a research note on Tuesday, February 4th. TD Cowen raised Cardinal Health from a "hold" rating to a "buy" rating and raised their price target for the stock from $130.00 to $144.00 in a research note on Wednesday, January 8th. Finally, Jefferies Financial Group upgraded Cardinal Health from a "hold" rating to a "buy" rating and increased their target price for the stock from $140.00 to $150.00 in a research note on Wednesday, February 5th. Four equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company's stock. Based on data from MarketBeat, Cardinal Health has a consensus rating of "Moderate Buy" and an average price target of $140.86.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.